| Notifiable Condition |
Time Frame for
Notification |
Notifiable to Local
Health Department |
Notifiable to State
Department of Health |
| Acquired Immunodeficiency Syndrome
(AIDS) |
Within 3 business
days |
√ |
|
| Animal Bites (when human exposure to
rabies is suspected) |
Immediately |
√ |
|
| Anthrax |
Immediately |
√ |
|
| Arboviral Disease (acute disease only
including, but not limited to, West Nile
virus, eastern and western equine
encephalitis, dengue, St. Louis
encephalitis, La Crosse encephalitis,
Japanese encephalitis, and Powassan) |
Within 3 business
days |
√ |
|
| Asthma, occupational |
Monthly |
|
√ |
| Birth Defects – Autism Spectrum
Disorders |
Monthly |
|
√ |
| Birth Defects – Cerebral Palsy |
Monthly |
|
√ |
| Birth Defects – Alcohol Related Birth
Defects |
Monthly |
|
√ |
| Botulism (foodborne, infant, and
wound) |
Immediately |
√ |
|
| Brucellosis (Brucella species) |
Within 24 hours |
√ |
|
| Burkholderia mallei (Glanders) and
pseudomallei (Melioidosis) |
Immediately |
√ |
|
| Campylobacteriosis |
Within 3 business
days |
√ |
|
| Chancroid |
Within 3 business
days |
√ |
|
| Chlamydia trachomatis infection |
Within 3 business
days |
√ |
|
| Cholera |
Immediately |
√ |
|
| Cryptosporidiosis |
Within 3 business
days |
√ |
|
| Cyclosporiasis |
Within 3 business
days |
√ |
|
| Diphtheria |
Immediately |
√ |
|
| Disease of suspected bioterrorism origin |
Immediately |
√ |
|
| Domoic acid poisoning |
Immediately |
√ |
|
| E. coli – Refer to "Shiga
toxin-producing E. coli" |
Immediately |
√ |
|
| Emerging condition with outbreak
potential |
Immediately |
√ |
|
| Giardiasis |
Within 3 business
days |
√ |
|
| Gonorrhea |
Within 3 business
days |
√ |
|
| Granuloma inguinale |
Within 3 business
days |
√ |
|
| Haemophilus influenzae (invasive
disease, children under age 5) |
Immediately |
√ |
|
| Hantavirus pulmonary syndrome |
Within 24 hours |
√ |
|
| Hepatitis A (acute infection) |
Within 24 hours |
√ |
|
| Hepatitis B (acute infection) |
Within 24 hours |
√ |
|
| Hepatitis B surface antigen + pregnant
women |
Within 3 business
days |
√ |
|
| Hepatitis B (chronic infection) – Initial
diagnosis, and previously unreported
prevalent cases |
Monthly |
√ |
|
| Hepatitis C (acute infection) |
Within 3 business
days |
√ |
|
| Hepatitis C (chronic infection) |
Monthly |
√ |
|
| Hepatitis D (acute and chronic infection) |
Within 3 business
days |
√ |
|
| Hepatitis E (acute infection) |
Within 24 hours |
√ |
|
| Herpes simplex, neonatal and genital
(initial infection only) |
Within 3 business
days |
√ |
|
| Human immunodeficiency virus (HIV)
infection |
Within 3 business
days |
√ |
|
| Influenza, novel or unsubtypable strain |
Immediately |
√ |
|
| Influenza-associated death (lab
confirmed) |
Within 3 business
days |
√ |
|
| Legionellosis |
Within 24 hours |
√ |
|
| Leptospirosis |
Within 24 hours |
√ |
|
| Listeriosis |
Within 24 hours |
√ |
|
| Lyme Disease |
Within 3 business
days |
√ |
|
| Lymphogranuloma venereum |
Within 3 business
days |
√ |
|
| Malaria |
Within 3 business
days |
√ |
|
| Measles (rubeola) – acute disease only |
Immediately |
√ |
|
| Meningococcal disease (invasive) |
Immediately |
√ |
|
| Monkeypox |
Immediately |
√ |
|
| Mumps (acute disease only) |
Within 24 hours |
√ |
|
| Outbreaks of suspected foodborne
origin |
Immediately |
√ |
|
| Outbreaks of suspected waterborne
origin |
Immediately |
√ |
|
| Paralytic shellfish poisoning |
Immediately |
√ |
|
| Pertussis |
Within 24 hours |
√ |
|
| Pesticide poisoning (hospitalized, fatal,
or cluster) |
Immediately |
|
√ |
| Pesticide poisoning (all other) |
Within 3 business
days |
|
√ |
| Plague |
Immediately |
√ |
|
| Poliomyelitis |
Immediately |
√ |
|
| Prion disease |
Within 3 business
days |
√ |
|
| Psittacosis |
Within 24 hours |
√ |
|
| Q Fever |
Within 24 hours |
√ |
|
| Rabies (Confirmed Human or Animal) |
Immediately |
√ |
|
| Rabies, suspected human exposure
(suspected human rabies exposures due
to a bite from or other exposure to an
animal that is suspected of being
infected with rabies) |
Immediately |
√ |
|
| Relapsing fever (borreliosis) |
Within 24 hours |
√ |
|
| Rubella (including congenital rubella
syndrome) (acute disease only) |
Immediately |
√ |
|
| Salmonellosis |
Within 24 hours |
√ |
|
| SARS |
Immediately |
√ |
|
| Serious adverse reactions to
immunizations |
Within 3 business
days |
√ |
|
| Shiga toxin-producing E. coli infections
(enterohemorrhagic E. coli including,
but not limited to, E. coli O157:H7) |
Immediately |
√ |
|
| Shigellosis |
Within 24 hours |
√ |
|
| Smallpox |
Immediately |
√ |
|
| Syphilis |
Within 3 business
days |
√ |
|
| Tetanus |
Within 3 business
days |
√ |
|
| Trichinosis |
Within 3 business
days |
√ |
|
| Tuberculosis |
Immediately |
√ |
|
| Tularemia |
Immediately |
√ |
|
| Vaccinia transmission |
Immediately |
√ |
|
| Vancomycin-resistant Staphylococcus
aureus (not to include
vancomycin-intermediate) |
Within 24 hours |
√ |
|
| Varicella-associated death |
Within 3 business
days |
√ |
|
| Vibriosis |
Within 24 hours |
√ |
|
| Viral hemorrhagic fever |
Immediately |
√ |
|
| Yellow fever |
Immediately |
√ |
|
| Yersiniosis |
Within 24 hours |
√ |
|
| Other rare diseases of public health
significance |
Within 24 hours |
√ |
|
| Unexplained critical illness or death |
Within 24 hours |
√ |
|